For research use only. We do not sell to patients.
SBI-115
CAS No. : 882366-16-7
Biological Activity：SBI-115 is a TGR5 (GPCR19) antagonist. SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.
Research Area：Others
Targets：G protein-coupled Bile Acid Receptor 1
Related Screening Libraries:Bioactive Compound Library Plus;GPCR/G Protein Compound Library;Anti-Obesity Compound Library;Lipid Metabolism Compound Library ;
Related Small Molecules:Hyodeoxycholic acid-d5;Cholic acid 7-sulfate;Deoxycholic acid-13C;Deoxycholic acid sodium hydrate;Taurodeoxycholic acid sodium hydrate;INT-767;INT-777;BAR502;5-HT7R antagonist 1;PEN (human);TGR5 Receptor Agonist 3;Hyodeoxycholic acid;SB756050;Deoxycholic acid-d6;BAR501;GPBAR1-IN-3;TC-G 1005;TGR5 Receptor Agonist;CAY10789;FXR/TGR5 agonist 1
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
